查尔森合并症指数对合并急性肾损伤并接受连续肾脏替代治疗的脓毒症患者死亡风险的评估价值

盛松; 张艳虹; 马杭琨; 高洪阳; 黄烨

doi:10.13201/j.issn.1009-5918.2021.11.012

查尔森合并症指数对合并急性肾损伤并接受连续肾脏替代治疗的脓毒症患者死亡风险的评估价值

- 中国中医科学院西苑医院急诊科(北京, 100091)
基金项目:
2019国家中医药管理局中医药循证能力建设项目(No:ZZ13-024-4)

详细信息

通讯作者: 黄烨,E-mail:yellow_926@163

中图分类号: R459.7

收稿日期: 2021-06-04

Assessing the value of charlson comorbidity index for mortality risk in sepsis patients with acute kidney injury undergoing continuous renal replacement therapy

- Department of Emergency, Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, 100091, China

More Information

Corresponding author: HUANG Ye, E-mail: yellow_926@163

Received Date: 04 June 2021

摘要

摘要: 目的:探讨查尔森合并症指数(CCI)对合并急性肾损伤(AKI)并接受连续肾脏替代治疗(CRRT)的脓毒症患者28 d和90 d死亡风险的评估价值。方法:回顾性连续收集2009年1月-2016年9月韩国Health System Severance医院和Ilsan医院ICU中合并AKI并接受CRRT的脓毒症患者。收集CRRT启动时患者的人口学和临床资料、生化指标、CCI评分、SOFA评分、APACHEⅡ评分,CRRT启动后2 h尿量和总滤出量等数据。采用Kaplan-Meier(K-M)生存曲线、Log-Rank检验、比例风险回归模型(Cox)和趋势性检验分析CCI对28 d和90 d死亡的独立作用,同时采用分层分析和交互作用检验进行亚组分析。结果:本研究最终纳入794例合并AKI并行CRRT的脓毒症患者。K-M曲线和Log-rank检验显示高分CCI患者28 d和90 d死亡率显著高于低分CCI患者。经有向无环图和效应改变法调整混杂后多因素Cox回归和趋势性检验显示CCI与28 d和90 d死亡独立正相关(28 d死亡HR=1.05,95%CI:1.01~1.09,P=0.0155,90 d死亡HR=1.05,95%CI:1.01~1.09,P=0.0080),且两者之间存在显著线性趋势关系(趋势性检验P<0.05)。分层和交互作用检验发现MAP与CCI对90 d死亡存在显著交互作用。结论:CCI与AKI行CRRT的脓毒症患者28 d和90 d死亡风险独立正相关。
- 查尔森合并症指数 /
- 脓毒症 /
- 急性肾损伤 /
- 连续肾脏替代治疗 /
- 死亡风险
Abstract: Objective:To investigate the value of Charlson Comorbidity Index(CCI) in assessing the risk of death on day 28 and 90 in sepsis patients with acute renal injury(AKI) and continuous renal replacement therapy(CRRT).Methods:Retrospectively collected patients with sepsis undergoing CRRT in the ICU of Health System Severance Hospital and Ⅱsan Hospital in Korea from January 2009 to September 2016. The demographic and clinical data, biochemical indicators, CCI score, SOFA score, APACHEⅡ score, and urine output at two hours and total filtration volume were collected after CRRT initiation. Kaplan-Meier(K-M) survival curve, Log-rank test, proportional hazard regression model(Cox) and trend test were used to analyze the independent effect of CCI on day 28 and 90 mortality. In addition, stratified analysis and interaction test were used for subgroup analysis.Results:Seven hundred and ninty-four sepsis patients with AKI undergoing CRRT were finally included in this study. K-M curve and Log-rank test revealed the mortality rate in patients with high CCI was significantly higher than that in patients with low CCI on day 28 and 90. After adjustment for potential confounders by directed acyclic graph and effect change methods, multivariate Cox regression and trend test showed CCI was independently positively correlated with day 28 and 90 mortality(28 day mortality:HR=1.05,95%CI:1.01-1.09,P=0.0155; 90-day mortality:HR=1.05,95%CI:1.01-1.09,P=0.0080). Also, there was a significant linear trend relationship between them(trend test P< 0.05). The stratification and interaction test showed that there was a significant interaction between map and CCI on the 90 th day of death.Conclusion:CCI is independently and positively correlated with the risk of death on days 28 and 90 in sepsis patients with AKI undergoing CRRT.
- charlson comorbidity index /
- sepsis /
- acute kidney injury /
- continuous renal replacement therapy /
- mortality risk

HTML全文

参考文献(26)

[1]	Vincent JL,Sakr Y,Singer M,et al.Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017[J].JAMA,2020,323(15):1478-1487.
[2]	中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等.中国脓毒症早期预防与阻断急诊专家共识[J].临床急诊杂志,2020,21(7):517-529.
[3]	Prescott HC,Angus DC.Postsepsis Morbidity[J].JAMA,2018,319(1):91.
[4]	盛松,张艳虹,马杭琨,等.脓毒症合并急性肾损伤并接受连续肾脏替代治疗患者28 d死亡预测模型构建与验证[J].创伤与急危重病医学,2021,9(3):200-205,210.
[5]	Charlson M,Szatrowski TP,Peterson J,et al.Validation of a combined comorbidity index[J].J Clin Epidemiol,1994,47(11):1245-1251.
[6]	Koppie TM,Serio AM,Vickers AJ,et al.Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer[J].Cancer,2008,112(11):2384-2392.
[7]	Ferreira FL,Bota DP,Bross A,et al.Serial evaluation of the SOFA score to predict outcome in critically ill patients[J].JAMA,2001,286(14):1754-1758.
[8]	Lee H,Lim C W,Hong H P,et al.Efficacy of the APACHE Ⅱ score at ICU discharge in predicting post-ICU mortality and ICU readmission in critically ill surgical patients[J].Anaesth Intensive Care,2015,43(2):175-186.
[9]	边士淇,寿松涛,李望,等.查尔森合并症指数对脓毒症患者预后的评估价值[J].中国全科医学,2015,18(14):1637-1640.
[10]	崔云亮,李雨,张树柳,等.查尔森合并症指数联合序贯器官衰竭评分预测脓毒症患者的死亡风险[J].中华危重病急救医学,2014,26(1):41-45.
[11]	Jung SY,Kwon J,Park S,et al.Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy[J].PLoS One,2018,13(2):e0191290.
[12]	Mehta RL,Kellum JA,Shah SV,et al.Acute Kidney Injury Network:report of an initiative to improve outcomes in acute kidney injury[J].Crit Care,2007,11(2):R31.
[13]	薄禄龙,卞金俊,邓小明.2016年脓毒症最新定义与诊断标准:回归本质重新出发[J].中华麻醉学杂志,2016,36(3):259-262.
[14]	Bangalore S,Guo Y,Samadashvili Z,et al.Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction:Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery[J].Circulation,2016,133(22):2132-2140.
[15]	Filion KB,Azoulay L,Platt R W,et al.A Multicenter Observational Study of Incretin-based Drugs and Heart Failure[J].N Engl J Med,2016,374(12):1145-1154.
[16]	Talib S,Sharif F,Manzoor S,et al.Charlson Comorbidity Index for Prediction of Outcome of Acute Kidney Injury in Critically Ill Patients[J].Iran J Kidney Dis,2017,11(2):115-123.
[17]	von Elm E,Altman DG,Egger M,et al.The Strengthening the Reporting of Observational Studies in Epidemiology(STROBE)Statement:guidelines for reporting observational studies[J].Int J Surg,2014,12(12):1495-1499.
[18]	刘慧鑫,汪海波,汪宁.有向无环图在混杂因素识别与控制中的应用及实例分析[J].中华流行病学杂志,2020,41(4):585-588.
[19]	Weng HY,Hsueh YH,Messam LL,et al.Methods of covariate selection:directed acyclic graphs and the change-in-estimate procedure[J].Am J Epidemiol,2009,169(10):1182-1190.
[20]	Park SY,Freedman ND,Haiman CA,et al.Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations[J].Ann Intern Med,2017,167(4):228-235.
[21]	Farrar D,Fairley L,Santorelli G,et al.Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women:analysis of data from the Born in Bradford cohort[J].Lancet Diabetes Endocrinol,2015,3(10):795-804.
[22]	Sheng S.Mean arterial pressure and arterial stiffness in Japanese population:a secondary analysis based on a cross-sectional study[J].Blood Press Monit,2020,25(6):310-317.
[23]	Soria JC,Felip E,Cobo M,et al.Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung(LUX-Lung 8):an open-label randomised controlled phase 3 trial[J].Lancet Oncol,2015,16(8):897-907.
[24]	刘晓,刘志广,范志松,等.严重脓毒症与脓毒性休克患者预后分析[J].山东大学学报(医学版),2016,54(10):80-84.
[25]	Talbot D,Massamba VK.A descriptive review of variable selection methods in four epidemiologic journals:there is still room for improvement[J].Eur J Epidemiol,2019,34(8):725-730.
[26]	Euser AM,Zoccali C,Jager KJ,et al.Cohort studies:prospective versus retrospective[J].Nephron Clin Pract,2009,113(3):c214-217.